tscpvuoskari2014 eng web

2 | Turku Science Park Ltd. Annual Review 2014

Turku Science Park Ltd.'s mission is closely linked to the well-being of companies. Innovative, successful compa-nies that create jobs are the driving force behind the suc-cess of the Turku economic region, since without exper-tise, jobs and profitable companies, other benefits to be shared will also be few and far between.

High expertise business operations call for close co-opera-tion between universities and institutes of higher education, companies and the public sector. As a company focusing on enterprises and research, owned by the City of Turku, Turku Science Park Ltd. works in strategic partnership with

universities and institutes of higher education, as well as with both start-up and existing growth companies. We provide services for all sectors based on high expertise, but our focus areas are biotechnology (BioTurku® – life sciences), information and communication technology (ICT), as well as the chemistry sector and cleantech sector.

Turku Science Park Ltd. is an independent and impartial business service company, which has been promoting the operations of small and medium-sized businesses, based on high expertise, for more than 25 years. As a rule, our services are free of charge to clients.

TURKU SCIENCE PARK LTD. INNOVATE

TO ACCELERATE

Our focus areas are biotechnology (BioTurku® – life sciences), information and communication technology (ICT), as well as the chemistry sector and cleantech sector.

Turku Science Park Ltd. Annual Review 2014 | 3

The challenging economic times continued in Finland and around the world in 2014. Develop-ment has, in part, been characterised by duality. In Europe, some national economies are getting back on their growth paths, but in the outskirts of the continent, such as in Finland, develop-ment has been slower or even the opposite.

At the national level, the sustainability gap in the public economy is already beginning to weaken services and financing opportunities offered to companies. The role of municipal enterprise and innovation services is further highlighted due to government actions. Unfortunately, the municipal economic structure suffers from the same sustainability gap, and decision makers are finding it difficult to concentrate on the future under the pressure of current problems.

In Turku, the situation has been acknowledged and decisions have been made to tackle the issue of ever scarcer resources by means of co-operation. In order to improve the situa-tion, the City of Turku, Turku Science Park Ltd. and Turku-based institutes of higher education signed an innovation agreement in the sum-mer, which will enable them to develop opera-tions through more extensive co-operation. Cost savings are sought, although primarily the agreement aims to improve the existing range of services and thus generate more local suc-cesses. The agreement contains both opera-tive partnerships and bringing suitable actors from the signature parties to the same facilities.

TScP has been preparing a new hub of chem-istry-sector enterprises, based primarily on the circular economy, together with a large group of companies. This business park, based on co-operation between different companies and actors, will be located in the factory area of Raisio plc and is called Smart Chemistry Park. With the strong involvement of local institutes of higher education as well, the operations are

a great example of the opportunities provided by the Triple Helix model, even on a smaller scale. The operating model and developing it has also received plenty of nationwide atten-tion. Therefore, the launch of the hub is being funded by the Finnish Innovation Fund Sitra, among others.

The EU's new programme period also marked the beginning of a new funding period. This has created new opportunities, which TScP has also been seizing actively. The Enterprise Europe Network operations, aiming to assist companies seeking growth, wanted to find new consortia to implement the operations in differ-ent countries. The Finnish consortium included Finpro, the Helsinki Region Chamber of Com-merce and TScP. This role made it possible for TScP to seek and also to be granted the respon-sibility for providing advice in Finland to com-panies receiving funding from the EU's SME instrument. Our national role in both projects will expand our company's area of operation.

Growth-orientation highlighted in business operations is also taken into consideration in the internal development of our company. In the summer, we carried out a reorganisation, in which the old sector-based model was replaced with a model based on company life cycles. This enables us to be a trailblazer in offering operations based on cross-sector partnership. After all, the most significant new innovations are often created at the boundaries between sectors.

Rikumatti LevomäkiCEO, Turku Science Park Ltd.

REVIEWBY THE CEO


The Board of Directors elected at the Annual General Meeting consists of Pekka Sundman (Chairman), Seppo Lehtinen, Riitta Koskimies, Jorma Mattinen, Aleksi Randell, Matti Rihko, Jukka Rinnevaara and Kalervo Väänänen. Tuo-mas Heikkinen has been serving as the Secre-tary to the Board of Directors.

Rikumatti Levomäki served as the company’s CEO.

ASSESSMENT OF THE MOST IMPORTANT RISKS AND UNCERTAINTIES IN OPERATIONSIn connection with its strategy work, TScP assessed the risks and uncertainties related to the scope and structure of its operations, as well as other factors affecting the develop-ment of operations.

REPORT BY THE BOARD OF DIRECTORS

INCOME STATEMENTRevenue 4,120,917.58 €Materials and services 666,905.54 €Personnel costs 2,001,319.64 €Depreciation and impairments 21,292.89 €

Other operating expenses 1,083,336.83 €Operating profit 354,000.70 €Financial income and expenses 540,807.91 €

Net result -186,807.21 €

Other funding 2%

Project funding from the Centre for Economic Development, Transport

and the Environment 6%

Project funding from the EU and ESF 8%

Project funding from Tekes 4%

Funding from the Turku Region Development Centre 17%

Sales of services 3%

Lease revenue from the business incubator 3%

Project funding from the Regional Council of Southwest Finland 4%

Funding from the City of Turku 53%

There is uncertainty regarding the objective to expand the funding basis beyond the City of Turku. This uncertainty is affected by the amount of available funding, among other things. Due to the uncertain global economic situation, the investment risks have become more pronounced and also realised to a consid-erable extent recently. However, viewed against the overall situation, these risks are not con-sidered to be very significant.

FUTURE OUTLOOKThe implementation of the new Turku-based hub of enterprise and innovation services will continue in the coming years. The business development operations for start-up compa-nies will receive new facilities in autumn 2015, taking the operations to a completely new level. At the beginning of 2016, business service

actors will relocate to shared facilities, which will make it possible to increase joint opera-tions considerably.

The restrictions temporarily associated with the availability of new funding will be elimi-nated due to new sources of funding becoming available. The opportunities to receive external funding will make quality improvement and increased volume of operations possible.

BOARD OF DIRECTORS’ PROPOSAL FOR DIVIDENDSThe loss for the financial period was EUR 186,807.21. The Board proposes that no divi-dend be paid.

BALANCE SHEETAssetsNon-current assets 1,218,912.33 €Current assets 5,835,657.96 €Assets total 7,054,570.29 €LiabilitiesEquity 5,944,485.11 €Current liabilities 1,110,085.18 €Liabilities total 7,054,570.29 €

INCOME STATEMENTAND BALANCE SHEET 2014

DISTRIBUTION OF REVENUE

Turku Science Park Ltd. is a non-profit limited liability company. The operations are based on carrying out joint development projects commissioned by business and industry, institutes of higher education and the public sector, as well as assignments from the City of Turku. The distribution of revenue depicts the shares of different sources of funding in the 2014 operations.


The Baltic Sea Health Summit, focusing on life sci-ences, took place during the Turku Baltic Sea Days at the beginning of June. The event, organised by Turku Science Park, gathered together approximately 150 participants from Finland, the other Nordic countries, Estonia and Russia.

One of the main themes in the seminar was the future of biotechnology financing, which was also cov-ered in his address by Siegfried Bialojan, the leading life sciences expert in Europe. According to Bialojan, Europe is suffering from a lack of investor money, which drives innovations to the USA, where public listing is a feasible option to receive funding.

The experts considered the Baltic Sea Health Sum-mit a valuable opportunity to exchange ideas and to

Baltic Sea Health Summit for life sciences professionals from the Baltic region

Turku Science Park Ltd.'s services were used by

1518 persons representing

the private sector



institutes of higher education



the public sector


431 private individuals

Turku Science Park Ltd. assessed

42 new business ideas

Turku Science Park Ltd.'s representatives conducted

80Invest in

negotiations

The Turku region became the home of

3 new biotechnology and

ICT-sector companies

Siegfried Bialojan was one of the speakers at the Baltic Sea Health Summit.

More news: www.turkusciencepark.com/fi/spark-uutiset

INNOVATING TO ACCELERATE GROWTH IN 2014

BIOTURKU®

REPORT BY THE BOARD OF DIRECTORS

The Turku ICT Week, organised in April for the third time, again broke its attendee record. The week con-sisted of a total of 15 different ses-sions, primarily in the Turku Science Park area, and attracted more than 1,000 attendees.

The Turku ICT Week highlights ICT-sector companies and activi-ties in Southwestern Finland. The sessions are open to all, but the objective is to motivate and inspire

students, researchers and compa-nies, in particular. The week is coor-dinated by Turku Science Park Ltd., and a large group of ICT sector and business actors took part in organ-ising individual sessions. The topics of the sessions varied from health care to TV broadcasting to gaming to the industry.

The Turku ICT Week was created to bring together talent and organ-isations in our region. The 2014

event proved that this goal has been reached. The large number of par-ties helping to organise the event is also a sign of good co-operation between sector companies in the Turku region.

A record number of events and attendeesTURKU ICT WEEK 2014

network. According to Siegfried Bialojan, Turku is a leading biotechnology cluster and as such, an ideal location for a summit like this.

“The requirements of a successful bio cluster are understood in Turku: strong co-operation between basic research, hospitals and commercial enterprises. This kind of ecosystem, focusing on interaction, is key to the success of practically any cluster,” Bialojan says.

International networking was highlighted as the key factor for successful business operations and funding. The Baltic Sea Health Summit, organised for the first time, generated new partnerships through the partner event for experts.

The summit will become a recurring event in the health sector and biotechnology in Turku.

IN 2014


The Finnish Orion and the German Bayer, the tradi-tional leaders in pharmaceuticals development in Turku, continue to grow and make investments.

Orion's new pharmaceuticals plant, focusing on packaging and logistics operations, was commissioned in Salo in March. The investment created more than 100 jobs in Salo. Centralising the packaging opera-tions in Salo also made additional space available for pharmaceuticals manufacturing and new investments at Orion's plants in Turku and Espoo.

In July, the expansion of the Orion plant in Turku was completed, where the company manufactures tablets, creams and cancer drugs. The plant employs approxi-mately 700 people.

The hormonal IUD Mirena, the number one selling product of the Bayer plant in Turku, broke yet another sales record. The sales of the product family amounted

to as much as EUR 819 million in 2014. At the beginning of June, Orion and Bayer announced

global co-operation to finalise and bring to market Ori-on's partially developed prostate cancer drug ODM-201. Bayer will commercialise the androgen receptor inhibitor globally, and Orion will be in charge of man-ufacturing the drug.

According to Reijo Salonen, Orion's Senior Vice Presi-dent, Pharmaceutical Research and Development, the new co-operation model benefits all parties concerned – Bayer, which has recently concentrated on develop-ing new cancer treatments, and Orion, which works to discover innovative drug molecules. The third party benefiting from the co-operation are prostate cancer patients: the co-operation is expected to result in a drug that improves patients' quality of life considerably.

Orion made investments; Bayer’s Mirena broke records

Turku-based start-up companies and services designed for them were introduced in May. Turku Science Park Ltd., the student-driven start-up community Boost Turku and Creve, an incubator for the creative sector, presented the innovative and crea-tive start-up operations during the SparkUp Week. Companies which participated in the activities included Bhava Industries, Rumilus Design, Julja Finland and NaNi Design.

Start-up Journey, a business accel-eration programme by the Boost Turku association, again accelerated the business ideas of many young people and students in summer 2014. Sixteen teams participated and honed their ideas in the programme during the summer. At the end of the summer, the award for the best idea in the programme went to FakeFish, a developer of a game inspired by the Kalevala national epic.

The two-year Quarterback pro-ject was launched at the beginning of 2013, and last autumn it was extended until the end of March 2015. The project has created a gam-ing sector hub, called Game Turku, which has been promoting Turku-based gaming expertise and built co-operation between actors in the gaming sector. During the two years, the number of gaming-sector com-panies increased by 170 per cent and the number of employees in these companies grew by as much as 225 per cent. Currently, there are 25 gaming companies of different sizes in Turku, employing a total of 130 people.

Drug development company Faron Pharmaceuticals Oy and its research partnership network have developed a new promising drug to treat acute lung injury (ALI). About a third of those with acute lung injury (ALI) and its more severe form, acute respiratory distress syn-drome (ARDS), die from the disease. In the studies, the drug reduced the probability of mortality by more than 80 per cent.

DelSiTech Oy, a drug delivery and pharmaceuticals company, com-pleted a funding round in the spring, during which the company collected a sizeable equity investment from Finnish investors. In addition, Tekes granted the company nearly one mil-lion euros of product development funding. The volume of the entire funding round was close to EUR 1.7 million. The additional funding will accelerate the development of DelSiTech's own supergeneric drug products.

IN BRIEF

Orion/Tomi Parkkonen

The operations at the Orion plant in Salo began last spring.

PHARMACEUTICAL COMPANIES

Visitors from Iceland in OctoberIceland's Minister of Industry and Commerce, Rag-nheiður Elín Árnadóttir (second left), and Ambassa-dor Kristín Aðalbjörg Árnadóttir met Turku Science Park Ltd.'s representatives during their visit to Turku at the beginning of October. CEO Rikumatti Levomäki

(second right) and BioTurku Director Tero Piispanen discussed the opportunities to increase co-operation between Finnish and Icelandic biotechnology com-panies. As Finland's leading life sciences hub, Turku would be a natural partner for Icelandic companies.

INTERNATIONAL CO-OPERATION


The innovation agreement was signed by Sami Savolainen (left), Director of Services, Turku University of Applied Sciences; Kalervo Väänänen, Rector, University of Turku; Aleksi Randell, Mayor of Turku; Jorma Mattinen, Rector of Åbo Akademi University; and Rikumatti Levomäki, CEO of Turku Science Park Ltd.

Orion made investments; Bayer’s Mirena broke records

Working towards a new eraThe City of Turku and the providers of innovation ser-vices in the region's institutes of higher education signed an agreement on closer co-operation in the summer. An easy-access enterprise and innovation service hub serv-ing the entire Turku region will be gradually developed in the Turku Science Park area. The enterprise services in the Turku region will be provided under the same roof in the ICT-City of Turku Science Park by 2016. In addi-tion to Turku Science Park Ltd., the building will house the Turku Region Development Centre, the business service centre Potkuri, as well as research and devel-opment operations of institutes of higher education, such as the Brahea Centre of the University of Turku.

The reorganisation will also include the establishment of a new development environment for start-up com-panies in the Turku Science Park area. The facilities to

be completed in ElectroCity in autumn 2015 will bring together the services of start-up companies of Turku Science Park Ltd., Creve, an incubator for the creative sector in the Humak University of Applied Sciences, and the student-driven start-up community Boost Turku. The development environment is called SparkUp, and it will accelerate start-up activities in the region, increase the region's appeal and promote the commercialisation of innovations generated there.

The basis of the innovation agreement is customer orientation. In the future, it will be easier for entrepre-neurs and companies to find the services designed for them. Closer co-operation between various actors will make service provision faster and improve the actors' opportunities to meet the needs of business and industry.

Forendo Pharma Oy signed a licence agreement on the devel-opment and commercialisation of fispemifene with Apricus Biosciences Inc. in the USA. Fispemifene nor-malises low testosterone levels in men and has demonstrated efficacy on urinary tract issues and chronic prostate inflammation in preclinical studies. The licence agreement also provided Forendo with a prepay-ment of USD 12.5 million. In addi-tion, as objectives are met, Apricus will later pay Forendo various mile-stone payments, as well as royalties on the commercial targets met.

The company also announced a EUR 12 million additional funding for the development of a new phar-maceutical to treat endometriosis. In addition to the existing sharehold-ers, the funding round included two new shareholders, Novartis Venture Fund and MS Ventures.

Abacus Diagnostica Oy received the Born Global Award at the annual European Day of the Entre-preneur in Turku in June. Abacus is a molecular diagnostics company specialised in rapid DNA test-ing. In 2009, the company began developing the GenomEra technol-ogy for detecting pathogens and received private funding for it. In 2011, the company was granted the CE-IVD marking and began the sales of the clinical product in Europe. Thereafter, the company's revenue has grown nearly five-fold, and exports account for 80 per cent of its income.

The ArcDia International Ltd. diagnostics company inaugurated the new, 900 square-metre facility in the Trivium building in Turku Science Park. Now product devel-opment, production and market-ing all take place under the same roof. Located on the seventh floor in Trivium, ArcDia continues the devel-opment of the mariPOC concept and analyser (a testing system for the rapid diagnostics of respiratory infections). The product is already being exported to ten countries, and the registration phase is under way in China, Russia and Japan.

IN BRIEF

ENTERPRISE AND INNOVATION SERVICES IN TURKU

Upcon – a masterpiece by two Turku-based companiesLabrox Oy and Kaivogen Oy, both located in Turku, introduced their new Upcon concept at the 2014 Medica fair. The new upconversion reader will enable more accurate and faster marker tests with the help of nanoparticles.

“The reader provides very quick and reliable analy-ses of cardiac markers, for example, with the help of nanoparticles produced by Kaivogen. Therefore, it is well-suited for quick tests. Our goal is to obtain test results in approximately ten minutes or even quicker,” says Ida Erling, CEO of the product development com-pany Labrox.

Labrox was founded at the Protomo business incu-bator and is beginning to break even after just a few years of operation. In 2014, the company's revenue reached EUR 600,000.

Ida Erling displaying the new Upcon reader.Ann

e Ko

rtel

a

DIAGNOSTICS


In the autumn, Turku Science Park Ltd. organised the first Best Business Path competition. The goal of the competition aimed at researchers, research groups and instructors at Turku-based institutes of higher educa-tion and research institutions, was to discover new business ideas, products and services with consider-able commercial potential and to boost the establish-ment of new companies.

The winner of the EUR 20,000 prize for the best busi-ness idea was “MC-Patch – Microcurrent Wound Map-ping & Treatment System” by MCP Team, which con-sists of researchers from the Åbo Akademi University, Tampere University of Technology and Aalto University. The winning idea is a multi-function wound care sys-tem, designed for stimulating and monitoring difficult to heal chronic ulcers, skin grafts and surgical incisions.

Wound care system and micro controller winners of a new business idea competition

The second prize-winner was a team from the Uni-versity of Turku Technology Research Center, which developed a micro controller with ultra-low power consumption. By lowering the energy consumption of microprocessors, the device enables the application of the Internet of Things philosophy and wearable tech-nologies. The jury granted EUR 10,000 for the further development of the idea.

A total of 24 applications were submitted to the competition, including business ideas from all Turku-based institutes of higher education and a vast variety of sectors. All ideas submitted to the competition are eligible to seek inclusion in Turku Science Park Ltd.'s services for start-up companies.

American company seeking partners in TurkuThe HealthBIO seminar is the most prominent national gathering in the biotechnology sector annually. At the end of August 2014, the seminar again attracted 200 representatives from the sector and research organi-sations to Turku Science Park. In addition to speeches on topical issues, the event also offers an important networking opportunity.

The seminar, organised by Turku Science Park Ltd., got an extra boost from the representatives of US-based, multinational Becton, Dickinson & Co (BD), who also met counterparts from several Finnish and Turku-based biotechnology companies during their visit. BD is particularly interested in diagnostics and drug dosing products offering scalability. The company also values competence ecosystems and networks.

Ellen Strahlman, BD's Senior Vice President, and Reijo Salonen, Orion Corporation's Senior Vice President, Pharma-ceutical Research and Development.

Winners of the Best Business Path competition: Left: Jan-Erik Eriksson and Mikael Bergelin of MC Patch Team; right: Lauri Koskinen and Markus Hiienkari from the micro controller development team.

THE HEALTHBIO ANNUAL SEMINAR

THE BEST BUSINESS PATH

IN BRIEF

Abomics Oy launched the Gene Account database for storing genetic test results. The test results can be used for prescribing the cor-rect drug and dosage. The applica-tion converts information obtained through scientific research and the interpretation of this information into an understandable form, so that the patient also understands what was examined and why. The Gene Account database provides an easy and secure way for the patient and their caregivers to use the infor-mation. Abomics also introduced the Lääkkeeni mobile application, which offers a convenient method for recording and storing drug infor-mation and dosage and for using it in care. The application is avail-able for Windows Phone, iPhone and Android.

MetGen Oy, located in Kaarina, was recognised for its cleantech expertise in December. In an event in Lausanne, Switzerland, the Global Cleantech Cluster Associa-tion (GCCA) awarded the com-pany for the technology created for developing industrial enzymes. MetGen received the GCCA Later Stage Award in the biofuels / bio-energy category.

The Auria Biobank, located in connection with the University of Turku and the Turku University Hospital Tyks, was entered in Val-vira's biobank register in March. The biobank collects, for example, tissue and blood samples and information for future research and development projects. Auria's research area cov-ers, in particular, the fields of circu-lation, metabolism, oncology and neurology. The Auria biobank also increases Turku's appeal as a life sciences hub.

Turku-based innovations won sev-eral 2014 Innovation Awards granted by the Chemical Industry Federa-tion of Finland. The award winners included Orion Pharma Oy's drug treatment for the symptoms of Alz-heimer's disease and the system developed by PerkinElmer Oy for immune deficiency disease screen-ing in newborns. The purpose of the Innovation Awards is to encourage research and development teams in companies, universities and research institutions to create new chemical products and services.


New kind of development environment for SMEs in the chemistry sector

The quantity and competence of the chemistry sec-tor actors in Southwestern Finland were mapped in the regional preparation stage of the Innovative Cities (INKA) programme. This also gave rise to an idea of founding a new kind of enterprise hub for chemistry-sector technology. The idea rapidly received support from various actors, and at the beginning of 2014, action was taken to put the idea into practice. Negoti-ations were launched with Raisio plc to lease an R&D laboratory in the company's factory area for a new kind of innovation platform. The negotiations were led by Turku Science Park Ltd. and conducted in close inter-action with SMEs.

Things progressed quickly, and a lease agreement on the facilities was signed at the turn of the year. The operations were launched, and the first companies moved into the facility, Smart Chemistry Park, at the beginning of 2015. The operations could be launched primarily thanks to the start-up assistance received from Sitra, a subsidy from the City of Raisio, as well as the labour input by the City of Turku, or, in practice, Turku Science Park Ltd.

The continuity of operations is contingent on new funding after 2015. In addition to marketing the area and finding new companies to move in, this will be an important responsibility for Turku Science Park Ltd., a neutral facilitator in the operations, this year.

SMART CHEMISTRY PARK

The under-utilised laboratory facilities of the R&D Center in the Raisio factory area will serve companies located in the Smart Chemistry Park in the future.

High visibility for Turku Science Park Ltd. at the Turku Science FairTurku Science Park Ltd. was one of the exhibitors at the Science Fair, organised in the Turku Fair and Con-gress Center during the first weekend of October. Our green-toned booth offered information on Turku Science Park's services and topical projects. The other side of the booth was reserved for the Game Turku project we implemented. The project supports Turku-based gam-ing expertise and actors, and at the Fair, it focused on presenting the sector training opportunities provided

in Turku. Games developed by local gaming compa-nies were also on display. The Turku Science Fair was organised as part of the Turku International Book Fair and had 23,700 visitors.

We also invested in other visibility in other ways dur-ing the autumn. Before the Fair, we overhauled our website and published a new brochure, which provides a condensed description of the basis and objectives of our operations as well as our new service packages based on the operations. In addition, a small-scale newspaper ad campaign was carried out in October–November, primarily as a reminder to our corporate target group of our services.

As in previous years, we produced both printed and electronic brochures, press releases, news and newslet-ters, as well as an Annual Review. We also made more intensive use of social media.

Turku Science Park Ltd. and the Game Turku project together at the Turku Science Fair.

MARKETING & COMMUNICATION

IN BRIEF

The Monitori seminar, focusing on technology in the health and well-being sector, was organised in 2014 for the 10th time. In recent years, the arrangements have been carried out in co-operation between the Turku University School of Busi-ness, Turku University of Applied Sci-ences Business Administration, the ICT and biotechnology sectors, as well as Turku Science Park Ltd. The events have evolved into a forum for discussions in which the academia, providers and buyers of services, technology companies as well as sec-tor associations bring out their per-spectives. It has been important to approach the topic from a variety of angles and also take the viewpoints of patients and care personnel into consideration.

The Turku-based technology group Teleste celebrated its 60th anniver-sary in 2014. The company, founded by Olavi Ahonen, specialises in video and broadband technology and related services. The company has approximately 1,300 employees in 20 countries.

HyTest Ltd. manufactures mono-clonal antibodies and antigens for raw materials to the diagnostics industry. The company celebrated its 20th anniversary in 2014. To honour this milestone and to share part of its success, the company introduced the HyTest Cardiac Marker Award. The EUR 20,000 award was given to Paul Collinson, a clinical chem-istry consultant and cardiac marker professor from England.

The Turku Centre of Biotechnol-ogy was established 25 years ago. In 1989, the University of Turku and the Åbo Akademi University joined forces to create a high-class toolbox to benefit top research in Turku.

TUCS (Turku Center for Computer Science) celebrated its 20th anni-versary in 2014. TUCS was founded in 1994 to coordinate and carry out ICT-sector research and education at the University of Turku and Åbo Akademi University. More than 250 people are involved in TUCS, and the number of students in the study programmes coordinated by the cen-tre is more than 2,000.

Finland's leading, internationally recognised

life sciences cluster

SparkUp community, innovating to accelerate

growth in start-up companies

Smart Chemistry Park, a new kind of chemistry sector

business park in Raisio

ARE YOU THINKING ABOUT THE SUCCESS POTENTIAL

OF YOUR BUSINESS OR PRODUCT IDEA?

DO YOU NEED ADVICE FOR GROWING AND DEVELOPING YOUR

BUSINESS?

ARE YOU INTERESTED IN ISSUES RELATED TO INTERNATION-

ALISATION?

Turku Science Park Ltd.ACCELERATES THE CREATION OF NEW BUSINESS AND JOBS IN THE TURKU REGION

Turku Science Park Ltd. has long experience in promoting business ideas based on high technology to create profitable business oper-ations. Our experts are happy to help with all your questions concerning commercialisa-tion of research, planning of business, set-ting up a company, and acquiring funding.

Turku Science Park Ltd. is heavily involved in the operations of the SparkUp community, which will move to its own facility in autumn 2015. The company's traditional incubator operations will continue as part of the new organisation. The incubator and its labora-tory facilities will focus on companies in the life sciences sector.

FURTHER INFORMATION: Erik Lehtonen, Director, Services for start-up companies, +358 (0)40 546 0563

Turku Science Park Ltd.'s growth and devel-opment services offer support for business development, improving the effectiveness of research and development activities as well as arranging funding. We also promote the building of different co-operation models and development environments as well as partnership between companies, institutes of higher education, financiers and R&D organi-sations. Our extensive regional, national and international network is at your disposal.

Growth and development services also aim to facilitate the forwarding of public sector customers to area companies.

FURTHER INFORMATION: Marko Puh-tila, Director, Growth and development ser-vices, +358 (0)40 550 9560

Turku Science Park Ltd.’s internationalisa-tion services focus on building partnerships between Finnish and foreign players, provid-ing internationalisation training, and finding financing sources that support internation-alisation. We actively participate in, among others, the activities of the Enterprise Europe Network (EEN), which has operations in 50 countries. We also attend leading events and conferences in our top sectors – often together with our clients aspiring to enter international markets.

Turku Science Park Ltd. is also responsi-ble for the City of Turku Invest in activities.

FURTHER INFORMATION: Tero Piis-panen, Director, Internationalisation services and BioTurku®, +358 (0)400 781 683

POWERED BY TURKU SCIENCE PARK LTD

• Along the Helsinki motorway• Next to the Kupittaa railway station

• Within walking distance from the city centre

• Less than a 30-minute drive to the international airport

Turku University Hospital Tyks

17,500 employees

31,000 students

400 professors

TURKU SCIENCE PARK

TWO SCIENTIFIC UNIVERSITIES

University Åbo Akademi of Turku University

Turku University of Applied Sciences

Diaconia University of Applied Sciences

Novia University of Applied Sciences

over300 companies and organisations

www.turkusciencepark.com

tscpvuoskari2014 eng web

Documents